• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国非霍奇金淋巴瘤发病率和死亡率的变化趋势,1990-2019 年,并预测至 2030 年:疾病负担的未来展望。

Secular trends in incidence and mortality of non-Hodgkin's lymphoma in China, 1990-2019, and predictions to 2030: Outlook for the future burden of disease.

机构信息

School of Physical Education, Shanxi University, No. 92, Wucheng Road, Taiyuan 030006, China.

Department of Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, China.

出版信息

Tumori. 2024 Oct;110(5):348-354. doi: 10.1177/03008916241261166. Epub 2024 Aug 2.

DOI:10.1177/03008916241261166
PMID:39096014
Abstract

BACKGROUND

The aim of this study was to analyze the trend of non-Hodgkin's lymphoma incidence and mortality in China from 1990 to 2019, along with assessing the effects of age, period, and cohort, as well as to predict future trends.

MATERIAL AND METHODS

Using data from the Global Burden of Disease Study 2019 we calculated the estimated annual percentage changes in the incidence and mortality of non-Hodgkin's lymphoma. Age-period-cohort analysis was used to assess the independent effects of these elements. Incidence and mortality until 2030 were predicted using a Bayesian age-period-cohort approach.

RESULTS

During 1990-2019, there was a significant increase in the age-standardized incidence and mortality rate in non-Hodgkin's lymphoma. Strong effects of birth cohort and period on non-Hodgkin's lymphoma incidence and mortality were observed. In terms of prediction, future non-Hodgkin's lymphoma incidence and mortality in China will continue to increase, while the mortality rate will decrease; for women, both the rates are projected to rise, but they will remain lower than men.

CONCLUSIONS

Currently, the non-Hodgkin's lymphoma burden is high in China, and it is expected to continue increasing in the future. Policymakers need to prioritize addressing the factors contributing to sex differences in disease burden, including variations in environmental exposures and lifestyles among men and women.

摘要

背景

本研究旨在分析 1990 年至 2019 年中国非霍奇金淋巴瘤的发病和死亡趋势,评估年龄、时期和队列的影响,并预测未来的趋势。

材料与方法

利用 2019 年全球疾病负担研究的数据,我们计算了非霍奇金淋巴瘤发病率和死亡率的年估计百分比变化。采用年龄-时期-队列分析评估这些因素的独立影响。采用贝叶斯年龄-时期-队列方法预测 2030 年之前的发病和死亡情况。

结果

1990-2019 年,中国非霍奇金淋巴瘤的年龄标准化发病率和死亡率显著上升。出生队列和时期对非霍奇金淋巴瘤的发病和死亡率有很强的影响。就预测而言,中国未来非霍奇金淋巴瘤的发病率和死亡率将继续上升,而死亡率将下降;对于女性,预计这两个比率都会上升,但仍低于男性。

结论

目前,中国非霍奇金淋巴瘤的负担很高,预计未来还会继续增加。政策制定者需要优先解决导致疾病负担性别差异的因素,包括男性和女性之间环境暴露和生活方式的差异。

相似文献

1
Secular trends in incidence and mortality of non-Hodgkin's lymphoma in China, 1990-2019, and predictions to 2030: Outlook for the future burden of disease.中国非霍奇金淋巴瘤发病率和死亡率的变化趋势,1990-2019 年,并预测至 2030 年:疾病负担的未来展望。
Tumori. 2024 Oct;110(5):348-354. doi: 10.1177/03008916241261166. Epub 2024 Aug 2.
2
[Increasing incidence and mortality of non-Hodgkin lymphomas. An epidemiological review of recent studies on risk factors for non-Hodgkin lymphoma].[非霍奇金淋巴瘤的发病率和死亡率不断上升。关于非霍奇金淋巴瘤危险因素的近期研究的流行病学综述]
Med Klin (Munich). 2001 Feb 15;96(2):87-100. doi: 10.1007/pl00002183.
3
Burden of lymphoma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016.中国淋巴瘤负担,2006-2016 年:基于 2016 年全球疾病负担研究的分析。
J Hematol Oncol. 2019 Nov 19;12(1):115. doi: 10.1186/s13045-019-0785-7.
4
Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.中国类风湿关节炎发病率和死亡率的趋势及未来预测:基于 GBD 2021 数据的系统分析。
Clin Rheumatol. 2024 Sep;43(9):2799-2806. doi: 10.1007/s10067-024-07083-3. Epub 2024 Jul 29.
5
Non-Hodgkin's lymphomas in Alexandria, Egypt; incidence rates and trend study (1995-2004).埃及亚历山大市的非霍奇金淋巴瘤;发病率及趋势研究(1995 - 2004年)
Eur J Cancer Prev. 2007 Oct;16(5):479-85. doi: 10.1097/01.cej.0000243858.91642.c9.
6
Hodgkin's and non-Hodgkin's lymphomas.霍奇金淋巴瘤和非霍奇金淋巴瘤。
Cancer Surv. 1994;19-20:423-53.
7
[Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].[1990年至2030年中国酒精所致肝硬化及其他慢性肝病疾病负担的分析与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):185-191. doi: 10.3760/cma.j.cn112338-20230920-00173.
8
Recent trends and future projections of lymphoid neoplasms--a Bayesian age-period-cohort analysis.淋巴瘤的近期趋势及未来预测——贝叶斯年龄-时期-队列分析
Cancer Causes Control. 2001 Nov;12(9):813-20. doi: 10.1023/a:1012240117335.
9
Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.霍奇金淋巴瘤儿童、青少年及年轻成人幸存者心血管疾病发病的累积负担:来自圣裘德终身队列研究的分析
Lancet Oncol. 2016 Sep;17(9):1325-34. doi: 10.1016/S1470-2045(16)30215-7. Epub 2016 Jul 25.
10
Global burden and prediction study of cutaneous squamous cell carcinoma from 1990 to 2030: A systematic analysis and comparison with China.全球 1990 年至 2030 年皮肤鳞状细胞癌的负担和预测研究:与中国的系统分析和比较。
J Glob Health. 2024 May 3;14:04093. doi: 10.7189/jogh.14.04093.

引用本文的文献

1
Electrochemical-assisted scattering imaging system for lymphoma cell classification using machine learning.基于机器学习的用于淋巴瘤细胞分类的电化学辅助散射成像系统
Biomed Opt Express. 2025 Jul 29;16(8):3424-3436. doi: 10.1364/BOE.569911. eCollection 2025 Aug 1.
2
Trends of Non-Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020.2000年至2020年美国成年人非霍奇金淋巴瘤发病率趋势
Cancer Rep (Hoboken). 2025 Jul;8(7):e70269. doi: 10.1002/cnr2.70269.